insights_auto
Por qué ha subido SOBI 2,28%?
Profundizarchevron_right
SOBI:STO
Swedish Orphan Biovitrum AB (publ)
493,60 SEK
arrow_upward
+2,28%(+11,00) 1 d
5 nov, 17:29:44 GMT+1 · SEK
search
Todos los símbolos
| Símbolo | Precio | Cambio | % de cambio |
|---|
insights_autoGenerando estadísticas principales de SOBI...
Abrir
486,00 SEK
Alto
496,00 SEK
Bajo
484,20 SEK
Cap. burs.
176,53 mil M
Vol. medio
337,83 mil
Volumen
378,84 mil
Ratio PER
26,22
Máximo en 52 sem.
496,00 SEK
Mínimo en 52 sem.
314,40 SEK
BPA
18,83 SEK
Acciones en circulación
357,64 M
N.º de empleados
2 mil
Abrir
486,00 SEK
Alto
496,00 SEK
Bajo
484,20 SEK
Cap. burs.
176,53 mil M
Vol. medio
337,83 mil
Volumen
378,84 mil
Ratio PER
26,22
Máximo en 52 sem.
496,00 SEK
Mínimo en 52 sem.
314,40 SEK
BPA
18,83 SEK
Acciones en circulación
357,64 M
N.º de empleados
2 mil
Noticias
De fuentes web y partners de noticias
TradingView
·
hace 2 días
Swedish Orphan Biovitrum Executive Sells, Buys Shares
Perfil
Sobi - Swedish Orphan Biovitrum AB is an international biopharmaceutical company focused on rare diseases. The company develops, commercializes, and delivers therapies in the fields of haematology, immunology and specialty care. Headquartered in Stockholm, Sweden, with major hubs in Basel, Switzerland, and Waltham, USA.
Sobi has a global presence in approximately 30 countries and provides medicines to patients in many more around world. The company develops treatments for patients living with complex and chronic rare conditions and maintains a pipeline of development and lifecycle management programs focused on advancing innovative therapies for diseases with significant unmet medical needs. Wikipedia
Acerca de Swedish Orphan Biovitrum AB (publ)